Filing Details
- Accession Number:
- 0001209191-21-059149
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-04 18:58:29
- Reporting Period:
- 2021-10-01
- Accepted Time:
- 2021-10-04 18:58:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178879 | Amicus Therapeutics Inc. | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1400971 | L Bradley Campbell | C/O Amicus Therapeutics, Inc. 3675 Market Street Philadelphia PA 19104 | Chief Operating Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-10-01 | 10,515 | $4.38 | 467,783 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-10-01 | 10,515 | $10.00 | 457,268 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (right to buy) | Disposition | 2021-10-01 | 10,515 | $0.00 | 10,515 | $4.38 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,030 | 2022-06-04 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- All of the options were fully vested and exercisable as of the transaction date.